Latest News - Elevance Health
Top Corporates Hub
Elevance Health
Barclays Maintains Overweight on Elevance Health, Raises Price Target to $469
07.10.2026 10:15
Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $457 to $469.
Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
05.10.2026 12:00
INDIANAPOLIS, October 05, 2026--Elevance Health (NYSE: ELV) will release third quarter 2026 financial results on October 21, 2026 at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:
UnitedHealth Group: Getting Cheaper And Cheaper
05.10.2026 08:00
UnitedHealth Group (UNH) remains a Buy, with fundamentals improving and valuation at a decade low P/E of 19.95 despite peer discounts.
UnitedHealth Group: Getting Cheaper And Cheaper
05.10.2026 08:00
UnitedHealth Group (UNH) remains a Buy, with fundamentals improving and valuation at a decade low P/E of 19.95 despite peer discounts.
Elevance Health (ELV): Conviction Pays Off as Underwriting Disciplines Stabilize Margins
01.10.2026 15:43
Cambiar Opportunity Fund, managed by Cambiar Investors, published its Q2 2026 investor letter. The letter can be downloaded here. U.S. equity markets experienced a significant rebound in Q2, with the S&P 500 rising 15.2% and the Russell 2000 up 21.5%. Growth stocks outperformed value, although value retained a year-to-date lead. The market’s rise was fueled […]
Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
01.10.2026 11:00
INDIANAPOLIS, October 01, 2026--Elevance Health (NYSE: ELV) announced today that its affiliated health plans will offer 2027 Medicare Advantage plans designed to help members navigate healthcare more confidently through meaningful choice, simpler benefit experiences and personalized support that reflects individual health needs.
Did UnitedHealth Name The Fix Before Its Stock Ran?
23.09.2026 16:26
UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 500. Read cold, that looks like a recovery nobody could have timed. It was not hidden. The company had said plainly, months before the shares turned, that it would give up members to rebuild margin.
How Centene's Strong Cash Flow Is Reshaping Its Balance Sheet
22.09.2026 11:01
Centene's robust cash flow is helping cut debt, with a lower debt-to-capital ratio and added liquidity reshaping its balance sheet.
Elevance Health (ELV) Stock May Be Below Fair Value As Guidance Was Reaffirmed
20.09.2026 06:12
Elevance Health has delivered a 1 year gain that puts the stock firmly on investors' radar, and the latest reaffirmed earnings outlook has only sharpened the focus on what you are paying for each dollar of profit. With the price around US$410.95 at the last close, the key issue now is whether that tag lines up with the insurer's earnings power. The stock is up 33.6% over the past year, which raises the question of whether that move is grounded in its underlying earnings profile. Management...
Should You Buy Elevance Health Stock For The Margin It Lost?
10.09.2026 19:36
Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.
Elevance Health Inc's Dividend Analysis
10.09.2026 11:04
Elevance Health Inc (NYSE:ELV) recently announced a total dividend of $1.72 per share, with the ex-dividend date set for 2026-09-10. For investors, the ex-dividend date is a critical marker: shareholders must own the stock before this date to qualify for the upcoming payment. As investors look forward to this next distribution, the spotlight also shines on the company's dividend history, yield, and growth rates.
Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run
04.09.2026 17:08
After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
04.09.2026 16:04
UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.
U.S. Health Insurers Raise Outlooks Despite Q2 Cost Rises, Shifting Membership
18.08.2026 04:41
In an ongoing trend, many leading managed care insurers saw shifts in membership, notably in the senior-focused, government-subsidized Medicare Advantage plans.
IHF: Healthcare Dashboard For August
16.08.2026 08:06
Healthcare sector valuation check: equipment undervalued, providers near baseline, pharma/biotech overvalued. Learn more about IHF ETF here.
Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs
14.08.2026 09:48
Mark Cuban is urging funds to divest from major health insurers. Here’s how broad-market ETFs remain exposed to the companies he’s targeting.
Encompass Health Beats Q2 Earnings Estimates, Raises '26 View
07.08.2026 15:47
EHC beats Q2 earnings estimates as higher patient revenues and strong discharge growth drive results, leading the company to raise its 2026 adjusted EPS outlook.
Elevance Health (ELV) After Its Cancer Care Push, Does The Valuation Still Look Attractive##
01.08.2026 09:12
Elevance Health (ELV) recently highlighted an expanded connected cancer care model that uses predictive analytics and dedicated oncology support to coordinate treatment, reduce avoidable complications, and provide more personalized resources across patients’ entire care journeys. See our latest analysis for Elevance Health. Against this backdrop, Elevance Health’s share price is US$375.84, with a year to date share price return of 6.09%. The 1 month share price return is down 9.70%, although...
Elevance Health’s CEO started her career as a pro basketball player. Now she’s the highest‑ranking woman on the Global 500, leading a $199B giant
31.07.2026 07:00
Gail Boudreaux credits collegiate athletics with helping to shape her leadership style.
Investors’ Favour Strengthens Elevance Health’s (ELV) Rebound
30.07.2026 13:31
Investment management company Vulcan Value Partners recently released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. Vulcan Value Partners prioritizes long-term returns and lower risk over short-term performance. In the quarter, the Large Cap Composite (Net) returned 9.5%, the Small Cap Composite (Net) returned 13.3%, the Focus Composite (Net) returned 10.4%, the […]